On February 22, Minister of Foreign Affairs Mukhtar Tleuberdi met with a delegation headed by Pfizer Regional Director for Europe, Asia and Africa Ozgur Yaziyurt. The interlocutors discussed the possibility of expanding the presence of the American company in Kazakhstan and localizing Prevenar-13 vaccine production, the press office of the Ministry of Foreign Affairs reported to CentralAsia.news.
The Kazakh side informed the interlocutors about the measures taken in the country to improve legislation to attract biopharmaceutical TNCs to the Kazakh market. The representatives of the company positively evaluated the ongoing efforts and the ongoing changes in the pharmaceutical regulations and legal acts.
Pfizer – an American multinational corporation headquartered in New York is one of the leaders in the biopharmaceutical market. Currently, it is developing the drugs for cardiovascular and musculoskeletal diseases and produces antibiotics, Viagra and immunosuppressants, among other medications. In 2020, BioNTech, Pfizer and Fosun Pharma jointly developed a COVID vaccine.
